Meet Kevin Marsh, PhD, Senior Research Leader of Patient-Centered Research at Evidera.

Kevin Marsh

PhD, Executive Director, Commercial Strategy and New Product Development, Patient-Centered Research

Kevin completed his PhD at the University of Bath, specializing in economic valuation techniques. After a year at Oxford University, he joined the Matrix Knowledge Group in London, where he built their economics practice. He joined the Evidera London office in April 2012.

Kevin is an expert in the use of preference information and decision analysis to inform health decisions, including pipeline optimization, authorization, reimbursement, and prescription decisions. His research interests include preference elicitation, decision modeling, and multiple-criteria decision analysis (MCDA).

Kevin co-chaired the ISPOR Taskforce on the use of MCDA in Health Care Decision-Making and is currently co-chairing an ISPOR Stated Preference Special Interest Group Working Group on the use of preference data in decision making in Europe. He is an active member of the Campbell and Cochrane Economic Methods Group, and has taught short courses in the use of MCDA in healthcare (ISPOR) and preference elicitation methods (SMDM).

Kevin has applied preference elicitation and decision analysis methods for a range of organizations, including both regulatory and industry clients. The former has included the National Institute for Health and Care Excellence, the National Institute for Health Research, and the Department of Health.